Liposomal Annamycin

annamycin liposome · Moleculin Biotech, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Liposomal Annamycin, covering 2007-12-21 to 2025-09-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

See pricing